Amlodipine and Burkitt lymphoma - a phase IV clinical study of FDA data

Summary:

Burkitt lymphoma is reported as a side effect among people who take Amlodipine (amlodipine besylate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Prednisolone, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Burkitt lymphoma when taking Amlodipine. It is created by eHealthMe based on reports of 346,875 people who have side effects when taking Amlodipine from the FDA, and is updated regularly.

What is Amlodipine?

Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 354,829 Amlodipine users. Check the latest studies of Amlodipine.

What is Burkitt lymphoma?

Burkitt lymphoma (cancer of the lymphatic system) is found to be associated with 375 drugs and 811 conditions by eHealthMe. Check the latest studies of Burkitt lymphoma.



On Jul, 26, 2026

346,875 people reported to have side effects when taking Amlodipine.
Among them, 57 people (0.02%) have Burkitt lymphoma.

Could Amlodipine cause Burkitt lymphoma?

Among these 57 people:

How long have people been on Amlodipine when they have Burkitt lymphoma? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Burkitt lymphoma when taking Amlodipine? *

  • female: 35.71 %
  • male: 64.29 %

What is the age of people who have Burkitt lymphoma when taking Amlodipine? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 2.08 %
  • 20-29: 0.0 %
  • 30-39: 2.08 %
  • 40-49: 0.0 %
  • 50-59: 25.0 %
  • 60+: 70.83 %

What are other drugs people take besides Amlodipine? *

  1. Humira: 9 people, 15.79%
  2. Prednisolone: 9 people, 15.79%
  3. Pantoprazole: 8 people, 14.04%
  4. Methotrexate: 6 people, 10.53%
  5. Vitamin D3: 6 people, 10.53%
  6. Digoxin: 5 people, 8.77%
  7. Risedronate Sodium: 5 people, 8.77%
  8. Omeprazole: 5 people, 8.77%
  9. Celecoxib: 5 people, 8.77%
  10. Remicade: 5 people, 8.77%

What are other side effects people have besides Burkitt lymphoma? *

  1. Fever: 6 people, 10.53%
  2. Psoas Abscess (collection of pus in the iliopsoas muscle compartment): 4 people, 7.02%
  3. Rashes (redness): 4 people, 7.02%
  4. Extranodal Marginal Zone B-Cell Lymphoma (Malt Type) (cancer originating from b cells in the marginal zone of the malt): 4 people, 7.02%
  5. Back Pain: 4 people, 7.02%
  6. Metastatic Gastric Cancer (cancer types can spread to the stomach from other place): 4 people, 7.02%
  7. Nausea (feeling of having an urge to vomit): 3 people, 5.26%
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 3 people, 5.26%
  9. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 5.26%
  10. Pneumonia: 3 people, 5.26%

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 13 people, 22.81%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 12.28%
  3. Osteoporosis (bones weak and more likely to break): 6 people, 10.53%
  4. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 7.02%
  5. Stress And Anxiety: 4 people, 7.02%
  6. Psoriasis (immune-mediated disease that affects the skin): 3 people, 5.26%
  7. Anaemia (lack of blood): 3 people, 5.26%
  8. Pityriasis Rubra Pilaris (reddish-orange colour scaling patches with well defined borders): 3 people, 5.26%
  9. Lymphocytosis (an increase in the number or proportion of lymphocytes in the blood): 2 people, 3.51%
  10. Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 2 people, 3.51%

* Approximation only. Some reports may have incomplete information.

Do you take Amlodipine and have Burkitt lymphoma?

- Check whether Burkitt lymphoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amlodipine:

Burkitt lymphoma treatments and more:

How severe was Burkitt lymphoma and when was it recovered:

Expand to all the drugs that have ingredients of amlodipine besylate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Amlodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Burkitt lymphoma:

Browse all the conditions that are associated with Burkitt lymphoma:


How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Amlodipine) and Amlodipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: